Graham I., Atar D., Boch-Johnsen К. et al. Fourth Joint Task Force of European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice// European Journal of Cardiovascular Prevention and Rehabilitation, 2007; 14 (Supp 2): S1-S113.
De Backer G., Ambrosioni E., Borch-Johnsen K. et al. Third Joint <…>by representatives of eight societies <…>. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J, 2003; 24: 1601–1610.
Riechman S. E., Andrews R. D., Maclean D. A., Sheather S.: Statins and dietary and serum cholesterol are associated with increased lean mass following resistance training. J Gerontol A Biol Sci Med Sci., 2007 Oct.; 62 (10): 1164–71.
Goldstein J. L., Brown M. S., Anderson R. G. W., Russel D. W., Schneider W. J. Receptor — mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell. Biol, 1985. 1:1–39.
Department of Medicine, University of Pittsburg, PA 15260. Muldoon M. F, Manuk S. В., Mattews K. A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990. Aug 11; 301:309–314.
Ravnskov Y.: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. British Medical Journal 1992. 305: 15–19.
Department of Public Health, University of Glasgow. Davey Smith G., Song R, Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993; 306: 1367–1373.
Department of Laboratory Medicine, School of Medicine, University of California, San Francisco. Newman Т. В., Hulley С. О. Carcinogenicity of lipid-lowering drugs. JAMA 1996; 275: 55–60.
Ziajka P. E., Wehmeier T. Peripheral neuropathy and lipid-lowering therapy. South Med. J, 1998; 91:667–68.
Gaist D., Jeppesen U., Andersen M., Garsia Rodriguez LA, Hallas L., Sindrup SH. Statins and risk of polyneuropathy: a case-control study. Neurology, 2002; 58:1333–7.
Golomb B. A., Kane T. Dimsdale J. E. Severe irritability associated with statin cholesterol lowering. QJM, 2004; 97:229–35.
Mann G. V. Coronary heart disease — «Doing the wrong things». Nutrition today 1985; July/August: 12–14.
Atrens D. M. The questionable wisdom of a low-fat diet and cholesterol reduction. Social Science & Medicine, 1994; 433–437.
McCormick J., Skrabanek P. Coronary heart disease is not preventable by population interventions. The Lancet, 1988; 2:839–41.
Skrabanek P.,McCormick J. Follies and fallacies in medicine. Tarragon Press: Glasgow, 1989.